← Back to SPRB

Spruce Biosciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 13/05/2026Sep 2025Filed 10/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 13/05/2026Sep 2024Filed 10/11/2025Jun 2024Filed 14/08/2025Mar 2024Filed 06/05/2025
$0$0$0$0.6$1.6$2
−$16−$12−$8.2−$2.1−$14−$8.7−$9.2−$12
−$6.68−$8.94−$14.58−$3.50−$23.95−$15.75−$16.73−$0.28
2.41.40.60.641

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.